These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular features of the cytolytic pore-forming bacterial protein toxins. Alouf JE Folia Microbiol (Praha); 2003; 48(1):5-16. PubMed ID: 12744072 [TBL] [Abstract][Full Text] [Related]
5. Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Geny B; Popoff MR Biol Cell; 2006 Nov; 98(11):667-78. PubMed ID: 17042742 [TBL] [Abstract][Full Text] [Related]
6. A rivet model for channel formation by aerolysin-like pore-forming toxins. Iacovache I; Paumard P; Scheib H; Lesieur C; Sakai N; Matile S; Parker MW; van der Goot FG EMBO J; 2006 Feb; 25(3):457-66. PubMed ID: 16424900 [TBL] [Abstract][Full Text] [Related]
7. [Bacterial Outer Membrane Nanovesicles: Structure, Biogenesis, Functions, and Application in Biotechnology and Medicine (Review)]. Lusta KA Prikl Biokhim Mikrobiol; 2015; 51(5):443-52. PubMed ID: 26596080 [TBL] [Abstract][Full Text] [Related]
8. The autotransporter secretion system. Desvaux M; Parham NJ; Henderson IR Res Microbiol; 2004 Mar; 155(2):53-60. PubMed ID: 14990256 [TBL] [Abstract][Full Text] [Related]
9. Assembling the puzzle: Oligomerization of α-pore forming proteins in membranes. Cosentino K; Ros U; García-Sáez AJ Biochim Biophys Acta; 2016 Mar; 1858(3):457-466. PubMed ID: 26375417 [TBL] [Abstract][Full Text] [Related]
10. Pore formation: an ancient yet complex form of attack. Iacovache I; van der Goot FG; Pernot L Biochim Biophys Acta; 2008; 1778(7-8):1611-23. PubMed ID: 18298943 [TBL] [Abstract][Full Text] [Related]
12. Enhanced SnapShot: Pore-forming toxins. Mueller M; Ban N Cell; 2010 Jul; 142(2):334, 334.e1. PubMed ID: 20655473 [No Abstract] [Full Text] [Related]
13. Bacterial protein toxins. An overview. Alouf JE Methods Mol Biol; 2000; 145():1-26. PubMed ID: 10820713 [No Abstract] [Full Text] [Related]
14. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971 [TBL] [Abstract][Full Text] [Related]
15. Channel formation by RTX-toxins of pathogenic bacteria: Basis of their biological activity. Benz R Biochim Biophys Acta; 2016 Mar; 1858(3):526-37. PubMed ID: 26523409 [TBL] [Abstract][Full Text] [Related]
16. Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxin. Lang AE; Neumeyer T; Sun J; Collier RJ; Benz R; Aktories K Biochemistry; 2008 Aug; 47(32):8406-13. PubMed ID: 18636745 [TBL] [Abstract][Full Text] [Related]
17. Genome sequencing. Search for pore-fection. Pennisi E Science; 2012 May; 336(6081):534-7. PubMed ID: 22556226 [No Abstract] [Full Text] [Related]
18. Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin-type of pore-forming bacterial toxins. Wu Q; Guo Z Med Res Rev; 2010 Mar; 30(2):258-69. PubMed ID: 19557762 [TBL] [Abstract][Full Text] [Related]
19. Pore-forming proteins and their application in biotechnology. Panchal RG; Smart ML; Bowser DN; Williams DA; Petrou S Curr Pharm Biotechnol; 2002 Jun; 3(2):99-115. PubMed ID: 12022262 [TBL] [Abstract][Full Text] [Related]